Table 3 Lymphocyte subsets in peripheral blood: cervical cancer versus precancerous lesion

Gran %CD45

3.05 ± 5.29

4.17 ± 6.17

0.522

T %MNC

57.41 ± 12.79

59.58 ± 9.54

0.575

rdT %T

7.30 ± 4.45

4.83 ± 2.22

0.067

B %MNC

6.05 ± 3.11

6.48 ± 2.48

0.644

pDC % MNC

0.25 ± 0.13

0.35 ± 0.16

0.022^#

CD11c + % pDC

7.62 ± 5.03

6.18 ± 1.97

0.386

Baso % MNC

0.98 ± 0.71

1.19 ± 0.60

0.334

BDCA1+ mDC % MNC

0.38 ± 0.18

0.65 ± 0.23

< 0.001^#

BDCA3+ mDC % MNC

0.17 ± 0.04

0.03 ± 0.05

0.374

Mono %MNC

15.56 ± 9.24

17.62 ± 8.01

0.473

CD14+ Mo % MNC

14.63 ± 6.98

16.98 ± 7.00

0.359

CD16+ Mo % MNC

3.07 ± 2.19

2.52 ± 1.04

0.448

CD16+ %Mono

15.58 ± 7.86

13.36 ± 3.29

0.020^#

NK %MNC

16.11 ± 9.34

10.90 ± 4.91

0.060

CD56hi NK % MNC

0.33 ± 0.15

0.29 ± 0.19

0.508

CD56lo NK % MNC

17.26 ± 9.62

10.36 ± 5.33

0.037^#

CD56hi %NK

2.54 ± 2.05

3.93 ± 3.03

0.106

MDSC % CD33hi

1.85 ± 3.32

3.42 ± 7.74

0.547

DR- %14 + APC

0.51 ± 1.55

0.38 ± 0.95

0.800

DR- %16 + APC

0.88 ± 1.60

0.44 ± 0.75

0.404